세계의 테이삭스병 치료 시장 보고서(2025년)

Tay-Sachs Disease Treatment Global Market Report 2025

US $ 4,490 ￦ 6,344,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,170,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,996,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

테이삭스병 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 연평균 성장률(CAGR) 7.3%로 32억 5,000만 달러로 성장할 것으로 예상됩니다. 예측 기간 동안의 성장은 라이소좀 저장 장애의 유병률 증가, 계발 활동 증가, 유전자 검사 서비스 확대, 대증 요법에 대한 수요 증가, 유전 질환의 유병률 상승 등으로 인한 것입니다. 주요 동향으로는 유전자 치료의 진보, 비용 효과적인 차세대 시퀀싱, 자동 복제 플랫폼, 약물전달 시스템의 혁신, AI와 머신러닝의 통합, 원격 의료 솔루션의 채택 등이 있습니다.

유전성 질환의 유병률 증가는 테이삭스병 치료 시장의 진보를 촉진할 것으로 예측됩니다. 유전성 질환은 유전성 또는 자연 돌연변이로 인한 개인의 DNA 이상으로 인한 것입니다. 이러한 질병 증가는 진단 방법의 개선, 의식 증가, 환경 요인, 육아 지연 및 라이프 스타일의 변화와 관련된 돌연변이 증가로 인한 것입니다. 유전성 질환 증가는 유전자 치료, 효소 보충, 조기 진단 연구에 박차를 가하고 테이삭스병 치료의 진보의 필요성을 강조하고 있습니다. 예를 들어, 2022년 2월 영국 정부 기관인 제노믹스 잉글랜드는 7,000개가 넘는 희귀질환이 인정되었으며, 영국에서는 약 17명 중 1명(350만 명)이 병을 앓고 있다고 보고했습니다. 그 결과, 유전성 질환의 유병률의 상승은 테이삭스병 치료 시장을 전진시킬 것으로 예측됩니다.

테이삭스병 치료 시장의 주요 기업은 유전자 치료, 효소 보충, 저분자 의약품 등 환자의 예후를 개선할 수 있는 치료법을 탐구하기 위해 임상시험을 포함한 혁신적인 치료에 주력하고 있습니다. 치료, 약제, 치료의 안전성, 효능, 잠재적 부작용을 평가하는 조사 연구입니다. 2024년 7월 미국 기반의 바이오 제약 회사인 IntraBio Inc.는 GM2 강글리오시드증(테이삭스 및 샌드호프병)을 표적으로 하는 IB1001의 임상시험(IB1001-202)을 실시하기 위한 임상시험약(IND) 신청에 대해 미국 식품의약국(FDA)의 승인을 받았다고 발표했습니다. 이 임상 시험은 현재 승인된 치료법이 없는 이러한 치명적인 신경퇴행성 질환들을 다루기 위해 미국, 영국, 독일, 스페인에서 진행되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 테이삭스병 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 테이삭스병 치료 시장 : 성장률 분석
• 세계의 테이삭스병 치료 시장 실적 : 규모와 성장, 2019-2024
• 세계의 테이삭스병 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계의 테이삭스병 치료 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 테이삭스병 치료 시장 : 치료별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 약
• 호흡 케어
• 물리치료
• 세계의 테이삭스병 치료 시장 : 투여 방법별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 주사제
• 오랄
• 기타 투여 방법
• 세계 테이삭스병 치료 시장 : 최종 사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 홈케어
• 전문 클리닉
• 기타 최종 사용자
• 세계의 테이삭스병 치료 시장 : 의약품유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 항 간질 약
• 미글 스탯
• 대증요법제
• 세계의 테이삭스병 치료 시장 : 호흡 케어 세분화(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 기계적 인공호흡기
• 기도 클리어런스 요법
• 산소요법
• 세계의 테이삭스병 치료 시장 : 물리치료유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 운동기능훈련
• 하이드로테라피
• 이동 보조 장치

제7장 지역별/국가별 분석

• 세계의 테이삭스병 치료 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 테이삭스병 치료 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 테이삭스병 치료 시장 : 경쟁 구도
• 테이삭스병 치료 시장 : 기업 프로파일
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• Biogen Inc.
• Vertex Pharmaceuticals Incorporated
• BioMarin Pharmaceutical Inc.
• Sarepta Therapeutics Inc.
• Ultragenyx Pharmaceutical Inc.
• Amicus Therapeutics Inc.
• Spark Therapeutics Inc.
• Rocket Pharmaceuticals Inc.
• RegenxBio Inc.
• Forge Biologics Inc.
• Passage Bio Inc.
• Protalix BioTherapeutics Inc.
• Orchard Therapeutics plc
• Affinia Therapeutics Inc.
• IntraBio Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 테이삭스병 치료 시장 2029 : 새로운 기회를 제공하는 국가
• 테이삭스병 치료 시장 2029 : 새로운 기회를 제공하는 부문
• 테이삭스병 치료 시장 2029 : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

SHW

영문 목차

영문목차

Tay-Sachs disease treatment encompasses therapeutic approaches aimed at managing or potentially curing this rare genetic disorder caused by a deficiency of the enzyme hexosaminidase A (Hex-A). Current treatment efforts include experimental gene therapy, substrate reduction therapy, and supportive care to alleviate symptoms and improve the quality of life for affected individuals.

The primary treatment options for Tay-Sachs disease include medication, respiratory care, and physical therapy. Medication involves prescribed drugs designed to relieve symptoms, slow disease progression, and enhance patient comfort by addressing pain, seizures, muscle stiffness, and related complications. These treatments are administered through various modes, including injectable, oral, and other methods, and are utilized in hospitals, homecare settings, and specialty clinics.

The tay-sachs disease treatment market research report is one of a series of new reports from The Business Research Company that provides tay-sachs disease treatment market statistics, including the tay-sachs disease treatment industry's global market size, regional shares, competitors with a tay-sachs disease treatment market share, detailed tay-sachs disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the tay-sachs disease treatment industry. This tay-sachs disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tay-sachs disease treatment market size has grown strongly in recent years. It will grow from $2.28 billion in 2024 to $2.45 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period can be credited to the increasing prevalence of Tay-Sachs disease, a greater focus on rare diseases, the rise in genetic screening initiatives, the growing demand for quality healthcare, and the overall increase in chronic condition cases.

The tay-sachs disease treatment market size is expected to see strong growth in the next few years. It will grow to $3.25 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth during the forecast period can be credited to the rising prevalence of lysosomal storage disorders, increasing awareness initiatives, the expansion of genetic testing services, growing demand for symptomatic treatments, and the rising prevalence of genetic diseases. Key trends include advancements in gene therapy, cost-effective next-generation sequencing, automated cloning platforms, innovations in drug delivery systems, the integration of AI and machine learning, and the adoption of telemedicine solutions.

The increasing prevalence of genetic diseases is expected to drive advancements in the Tay-Sachs disease treatment market. Genetic diseases result from abnormalities in an individual's DNA, either inherited or caused by spontaneous mutations. The rise in these conditions is attributed to improved diagnostics, heightened awareness, environmental factors, and higher mutation rates associated with delayed parenthood and lifestyle changes. The growing occurrence of genetic diseases underscores the need for advancements in Tay-Sachs disease treatment, fueling research in gene therapy, enzyme replacement, and early diagnostics. For example, in February 2022, Genomics England, a UK-based government organization, reported that over 7,000 recognized rare diseases affect approximately 1 in 17 people (3.5 million) in the UK. Consequently, the rising prevalence of genetic diseases is expected to drive the Tay-Sachs disease treatment market forward.

Leading companies in the Tay-Sachs disease treatment market are focusing on innovative therapies, including clinical trials, to explore potential treatments such as gene therapy, enzyme replacement, and small-molecule drugs for improved patient outcomes. Clinical trials are research studies that assess the safety, effectiveness, and potential side effects of medical treatments, drugs, or procedures in humans. For instance, in July 2024, IntraBio Inc., a US-based biopharmaceutical company, announced that it had received US Food and Drug Administration (FDA) approval for its Investigational New Drug (IND) Application to conduct a clinical trial (IB1001-202) for IB1001, targeting GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease). The trial is being conducted in the U.S., UK, Germany, and Spain to address these fatal neurodegenerative disorders, which currently have no approved treatments. IntraBio's chairman emphasized the urgent need to develop effective therapies for these debilitating conditions.

In June 2023, New Hope Research Foundation Inc., a US-based non-profit research organization, partnered with Forge Biologics Inc. to advance its innovative gene therapy, NHR01, into Phase I/II clinical trials for patients with Tay-Sachs disease and GM2 gangliosidosis. Forge Biologics, a US-based biotechnology company, specializes in gene therapy contract manufacturing and clinical-stage therapeutics.

Major players in the tay-sachs disease treatment market are Pfizer Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Ultragenyx Pharmaceutical Inc., Amicus Therapeutics Inc., Spark Therapeutics Inc., Rocket Pharmaceuticals Inc., RegenxBio Inc., Forge Biologics Inc., Passage Bio Inc., Protalix BioTherapeutics Inc., Orchard Therapeutics plc, Affinia Therapeutics Inc., IntraBio Inc., and Taysha Gene Therapies Inc.

North America was the largest region in the tay-sachs disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tay-sachs disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tay-sachs disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tay-sachs disease treatment market consists of revenues earned by providing services such as respiratory care, physical therapy, genetic counseling, and home care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The tay-sachs disease treatment market includes sales of anticonvulsants, gene therapy products, supportive care products, and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tay-Sachs Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tay-sachs disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tay-sachs disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tay-sachs disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Medication; Respiratory Care; Physical Therapy
• 2) By Mode Of Administration: Injectable; Oral; Other Mode Of Administration
• 3) By End-Users: Hospitals; Homecare; Specialty Clinics
• Subsegments:
• 1) By Medication: Antiepileptic Drugs; Miglustat; Supportive Symptomatic Medications
• 2) By Respiratory Care: Mechanical Ventilation; Airway Clearance Therapy; Oxygen Therapy
• 3) By Physical Therapy: Motor Function Exercises; Hydrotherapy; Assistive Mobility Devices
• Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Novartis AG; Takeda Pharmaceutical Company Limited; Regeneron Pharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tay-Sachs Disease Treatment Market Characteristics

3. Tay-Sachs Disease Treatment Market Trends And Strategies

4. Tay-Sachs Disease Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Tay-Sachs Disease Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tay-Sachs Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tay-Sachs Disease Treatment Market Growth Rate Analysis
• 5.4. Global Tay-Sachs Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tay-Sachs Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tay-Sachs Disease Treatment Total Addressable Market (TAM)

6. Tay-Sachs Disease Treatment Market Segmentation

• 6.1. Global Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Respiratory Care
• Physical Therapy
• 6.2. Global Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Oral
• Other Mode Of Administration
• 6.3. Global Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End User
• 6.4. Global Tay-Sachs Disease Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antiepileptic Drugs
• Miglustat
• Supportive Symptomatic Medications
• 6.5. Global Tay-Sachs Disease Treatment Market, Sub-Segmentation Of Respiratory Care, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mechanical Ventilation
• Airway Clearance Therapy
• Oxygen Therapy
• 6.6. Global Tay-Sachs Disease Treatment Market, Sub-Segmentation Of Physical Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Motor Function Exercises
• Hydrotherapy
• Assistive Mobility Devices

7. Tay-Sachs Disease Treatment Market Regional And Country Analysis

• 7.1. Global Tay-Sachs Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tay-Sachs Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tay-Sachs Disease Treatment Market

• 8.1. Asia-Pacific Tay-Sachs Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tay-Sachs Disease Treatment Market

• 9.1. China Tay-Sachs Disease Treatment Market Overview
• 9.2. China Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tay-Sachs Disease Treatment Market

• 10.1. India Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tay-Sachs Disease Treatment Market

• 11.1. Japan Tay-Sachs Disease Treatment Market Overview
• 11.2. Japan Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tay-Sachs Disease Treatment Market

• 12.1. Australia Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tay-Sachs Disease Treatment Market

• 13.1. Indonesia Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tay-Sachs Disease Treatment Market

• 14.1. South Korea Tay-Sachs Disease Treatment Market Overview
• 14.2. South Korea Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tay-Sachs Disease Treatment Market

• 15.1. Western Europe Tay-Sachs Disease Treatment Market Overview
• 15.2. Western Europe Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tay-Sachs Disease Treatment Market

• 16.1. UK Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tay-Sachs Disease Treatment Market

• 17.1. Germany Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tay-Sachs Disease Treatment Market

• 18.1. France Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tay-Sachs Disease Treatment Market

• 19.1. Italy Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tay-Sachs Disease Treatment Market

• 20.1. Spain Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tay-Sachs Disease Treatment Market

• 21.1. Eastern Europe Tay-Sachs Disease Treatment Market Overview
• 21.2. Eastern Europe Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tay-Sachs Disease Treatment Market

• 22.1. Russia Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tay-Sachs Disease Treatment Market

• 23.1. North America Tay-Sachs Disease Treatment Market Overview
• 23.2. North America Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tay-Sachs Disease Treatment Market

• 24.1. USA Tay-Sachs Disease Treatment Market Overview
• 24.2. USA Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tay-Sachs Disease Treatment Market

• 25.1. Canada Tay-Sachs Disease Treatment Market Overview
• 25.2. Canada Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tay-Sachs Disease Treatment Market

• 26.1. South America Tay-Sachs Disease Treatment Market Overview
• 26.2. South America Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tay-Sachs Disease Treatment Market

• 27.1. Brazil Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tay-Sachs Disease Treatment Market

• 28.1. Middle East Tay-Sachs Disease Treatment Market Overview
• 28.2. Middle East Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tay-Sachs Disease Treatment Market

• 29.1. Africa Tay-Sachs Disease Treatment Market Overview
• 29.2. Africa Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tay-Sachs Disease Treatment Market Competitive Landscape And Company Profiles

• 30.1. Tay-Sachs Disease Treatment Market Competitive Landscape
• 30.2. Tay-Sachs Disease Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tay-Sachs Disease Treatment Market Other Major And Innovative Companies

• 31.1. Biogen Inc.
• 31.2. Vertex Pharmaceuticals Incorporated
• 31.3. BioMarin Pharmaceutical Inc.
• 31.4. Sarepta Therapeutics Inc.
• 31.5. Ultragenyx Pharmaceutical Inc.
• 31.6. Amicus Therapeutics Inc.
• 31.7. Spark Therapeutics Inc.
• 31.8. Rocket Pharmaceuticals Inc.
• 31.9. RegenxBio Inc.
• 31.10. Forge Biologics Inc.
• 31.11. Passage Bio Inc.
• 31.12. Protalix BioTherapeutics Inc.
• 31.13. Orchard Therapeutics plc
• 31.14. Affinia Therapeutics Inc.
• 31.15. IntraBio Inc.

32. Global Tay-Sachs Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tay-Sachs Disease Treatment Market

34. Recent Developments In The Tay-Sachs Disease Treatment Market

35. Tay-Sachs Disease Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Tay-Sachs Disease Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tay-Sachs Disease Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tay-Sachs Disease Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료